ADO

0.00%

2.6¢ anteotech ltd

EuGeni, page-2253

First 2253 Last

levelhead

855 Posts.

219

03/05/22

11:46

Post #: 61168821

Originally posted by Sabbath: ↑
All I can say I've been banging on about this specifically for near 2 years. However I do accept what I post may be received in a number of different ways especially if it implies I am critical about how ADO go about doing 'business'.

My views and opinions have not changed even with new mgt. It may take many more months about how effective they are in promoting ADO into a credible disruptor in the battery space.

My next critique will be the 12 month result to see how much 'extra' they extracted from the updated Ellume supply contract, if they still can't do better than last years result, well it wouldn't have amounted for too much, not what we were told a few months ago.

Column 1 Column 2 Column 3 Column 4 Column 5 Column 6
1 Consolidated statement of cash flows Period Ending June 2020 Period Ending June 2021 Period Ending March 2022 Period Ending June 2022
2 Quarterlies Dates - 31/01 - 21/04 - 28/10 - 30/07 Year to date (12 months) $A’000 Year to date (12 months) $A’000 Year to date (9 months) $A’000 Year to date (12 months) $A’000
3
4 1 Cash flows from operating activities
5
6 1.1 Receipts from customers 279 889 566
7 1.2 Payments for
8 (a) research and development -593 -1,994 -1,733
9 (b) product manufacturing and operating costs -722 -470
10 (c) advertising and marketing -265 -342
11 (d) leased assets -322 -299 -317
12 (e) staff costs -2,240 -2,916 -3,823
13 (f) administration and corporate costs -576 -653 -940
14 1.3 Dividends received (see note 3)
15 1.4 Interest received 6 5 2
16 1.5 Interest and other costs of finance paid
17 1.6 Income taxes paid
18 1.7 Government grants and tax incentives 966 1,401 1,965
19 1.8 Other (ATO cash boost) 100
20 1.9 Net cash from / (used in) operating activities -2,745 -4,531 -5,156
Expand
Yes,
I am hoping it reflects Ellume stockpiling prior to the new agreement and so the 'much improved terms' upon which the new contract was negotiated (as declared by Derek), won't necessarily be obvious for the last or perhaps even current quarter.
I certainly expect they would be sensible and buy as much as they could based on the cheaper price.

ADO Price at posting: 11.0¢ Sentiment: Hold Disclosure: Held

2 Upvote

0 Great analysis

Top Stories

PME

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

KAU

Kaiser Reef reports new A1 untapped gold zone – flags move past 'remnant mining'

ASX Market Update: Index pulls back from record highs | October 16, 2024

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 413 more messages in this thread...

First 2253 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.6¢		Change 0.000(0.00%)		Mkt cap ! $64.73M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	247857	2.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.4¢	20000	1

View Market Depth

No.	Vol.	Price($)
2	247857	0.028
1	37037	0.027
6	969615	0.026
1	398800	0.025
3	1365217	0.023

Price($)	Vol.	No.
0.024	20000	1
0.026	111493	3
0.027	569350	2
0.028	464035	5
0.029	1229441	10

Last trade - 16.12pm 16/10/2024 (20 minute delay)

ADO (ASX) Chart

Day chart unavailable

EuGeni, page-2253

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

Kaiser Reef reports new A1 untapped gold zone – flags move past 'remnant mining'

ASX Market Update: Index pulls back from record highs | October 16, 2024

Battery Age Minerals gets set to capitalise on critical mineral demand

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6
1		Consolidated statement of cash flows	Period Ending June 2020	Period Ending June 2021	Period Ending March 2022	Period Ending June 2022
2		Quarterlies Dates - 31/01 - 21/04 - 28/10 - 30/07	Year to date (12 months) $A’000	Year to date (12 months) $A’000	Year to date (9 months) $A’000	Year to date (12 months) $A’000
3
4	1	Cash flows from operating activities
5
6	1.1	Receipts from customers	279	889	566
7	1.2	Payments for
8		(a) research and development	-593	-1,994	-1,733
9		(b) product manufacturing and operating costs		-722	-470
10		(c) advertising and marketing	-265	-342
11		(d) leased assets	-322	-299	-317
12		(e) staff costs	-2,240	-2,916	-3,823
13		(f) administration and corporate costs	-576	-653	-940
14	1.3	Dividends received (see note 3)
15	1.4	Interest received	6	5	2
16	1.5	Interest and other costs of finance paid
17	1.6	Income taxes paid
18	1.7	Government grants and tax incentives	966	1,401	1,965
19	1.8	Other (ATO cash boost)		100
20	1.9	Net cash from / (used in) operating activities	-2,745	-4,531	-5,156

EuGeni, page-2253

Top Stories

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

Kaiser Reef reports new A1 untapped gold zone – flags move past 'remnant mining'

ASX Market Update: Index pulls back from record highs | October 16, 2024

Battery Age Minerals gets set to capitalise on critical mineral demand

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News